2
5
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6S2122 |
Ginkgolic Acid (C13:0)
6-Tridecylsalicylic acid,Ginkgolic acid (13:0),Ginkgoneolic Acid,银杏酸C13:0,Ginkgolic acid C13:0 |
Antibacterial; Glucosidase | Metabolism; Microbiology/Virology |
Ginkgolic Acid (C13:0) (6-Tridecylsalicylic acid) 是一种天然防龋药,有抑菌活性。 | |||
T6S2123 |
Ginkgolic Acid
Romanicardic acid,Ginkgolic acid I,Ginkgolic acid (15:1),银杏酸C15:1,银杏酸,Ginkgolic acid C15:1 |
Others; E1/E2/E3 Enzyme | Others; Ubiquitination |
Ginkgolic Acid (Romanicardic acid) 是一种天然化合物, 在体外实验中抑制SUMOylation,IC50=3.0 μM。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPK-01373 |
Fibronectin Protein, Human, Recombinant (aa 1266-1356, hFc)
FINC,LETS,GFND,SMDCF,GFND2,ED-B,MSF,FNZ,FN... |
Human | HEK293 Cells |
Fibronectin is a high molecular glycoprotein present in the blood, connective tissue and at cell surface. It is synthesized by many types of differentiated cells and is believed to be involved in the attachment of cells to the surrounding extracellular matrix. Fibronectin has affinity to the other main components of extracellular matrix, collagen and glycosaminoglycans. Fibronectin Protein, Human, Recombinant (aa 1266-1356, hFc) is expressed in HEK293 mammalian cells with C-hFc tag. The predicte... | |||
TMPK-01391 |
Fibronectin Protein, Human, Recombinant (aa 1266-1356, His)
FN1,LETS,GFND,MSF,FNZ,CIG,ED-B,FN,SMDCF,GF... |
Human | HEK293 Cells |
Fibronectin is a high molecular glycoprotein present in the blood, connective tissue and at cell surface. It is synthesized by many types of differentiated cells and is believed to be involved in the attachment of cells to the surrounding extracellular matrix. Fibronectin has affinity to the other main components of extracellular matrix, collagen and glycosaminoglycans. Fibronectin Protein, Human, Recombinant (aa 1266-1356, His) is expressed in HEK293 mammalian cells with C-His tag. The predicte... | |||
TMPK-01450 |
HLA-C*03:04&B2M&KRAS G12D (GADGVGKSAL) Monomer Protein, Human, MHC (His & Avi), Biotinylated
KRAS1,MHC,K-RAS4B,KRAS,CFC2,K-RAS... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01456 |
HLA-C*03:04&B2M&KRAS G12D (GADGVGKSAL) Tetramer Protein, Human, MHC (His & Avi)
KRAS2,NS,MHC,C-K-RAS,KRAS1,K-RAS2A,K-RAS2B... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. | |||
TMPK-01451 |
HLA-C 03:04&B2M&KRAS G12D (GADGVGKSAL) Monomer Protein, Human, MHC (His & Avi)
NS3,K-RAS4A,K-Ras 2,NS,KRAS1,RASK2,MHC,KI-RAS,KRAS,... |
Human | HEK293 Cells |
Kirsten rat sarcoma 2 viral oncogene homolog (KRAS) is the most commonly mutated oncogene in human cancer. The developments of many cancers depend on sustained expression and signaling of KRAS, which makes KRAS a high-priority therapeutic target. The virtual screening approach to discover novel KRAS inhibitors and synthetic lethality interactors of KRAS are discussed in detail. |